相关实验视频

Updated: Sep 13, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

通过QM/MM方法,阿法提尼布与EGFR结合的热力学和机制

Anjali Kisku¹, Raghav Wahi¹, Raj Kumar Mishra¹

¹Department of Chemistry, Institute of Science, Banaras Hindu University Varanasi-221005 India rkmishra.chem@bhu.ac.in.

RSC medicinal chemistry

|August 4, 2025

概括

这项研究计算了阿法替尼和EGFR之间的热力学相互作用,这对于非小细胞肺癌 (NSCLC) 至关重要. 分子力学/Poisson-Boltzmann表面积 (MM/PBSA) 给出的结合自由能量比其他方法更接近实验值.

科学领域:

计算化学是一种计算化学.
分子动力学分子动力学
结构生物学是结构生物学.

背景情况:

阿法替尼是一种氨酸激酶抑制剂,向表皮生长因子受体 (EGFR).
EGFR与非小细胞肺癌 (NSCLC) 的发展有关.
准确计算药物标结合能量对于药物发现至关重要.

研究的目的:

计算阿法替尼和EGFR之间的热力学相互作用参数.
使用正常模式分析 (NMA),相互作用 (IE) 和C2方法进行结合性自由能量计算的比较.
评估MM/PBSA在预测结合能量的准确性.

主要方法:

分子力学/Poisson-Boltzmann表面积 (MM/PBSA) 的模拟.
正常模式分析 (NMA).
交互 (IE) 和C2计算方法.

主要成果:

MM/PBSA预测水合复合体的结合自由能量为 -19.86 kcal mol-1 ,与实验值 (~ -13.00 kcal mol-1) 非常接近.
通过IE和C2方法得到的值显著不同 (分别为-32.96和-35.47卡路里mol-1).
MM/PBSA显示了较低的标准偏差 (σ_IE = 3.54 kcal mol−1),表明结合趋同.

结论:

与IE和C2方法相比,MM/PBSA提供了更准确的阿法提尼布-EGFR结合自由能量估计.
精确的计算方法对于促进癌症治疗中的共价药物发现至关重要.
对于复杂的药物发现挑战,结构生物学和模拟技术的进一步进步是必要的.

更多相关视频

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis

Published on: January 7, 2017

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

相关概念视频

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Protein-Drug Binding: Mechanism and Kinetics

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...